The Kinase Domain and Membrane Localization Determine Intracellular Interactions between Epidermal Growth Factor Receptors (*)

  1. Andrew Chantry
  1. From the Departments of Biochemistry and Medical Oncology, Charing Cross and Westminster Medical School, Fulham Palace Road, London W6 8RP, United Kingdom

    Abstract

    Receptor tyrosine kinases play a central role in cellular growth, differentiation, and oncogenesis. All of these responses are triggered by growth factors interacting with the extracellular domain of transmembrane-spanning receptors, leading to dimerization and activation of an intrinsic tyrosine-specific kinase activity by an allosteric mechanism. Precise mechanisms of receptor dimerization remain poorly understood, and current models suggest that the ligand binding domain plays a major determining role. To examine the role of the intracellular domain in the association of juxtaposing receptor molecules, the full-length epidermal growth factor receptor was transiently co-expressed in human 293 fibroblasts with a truncated receptor that lacks the extracellular domain. After metabolic labeling with [GraphicS]methionine, the association of these receptor constructs was monitored by co-immunoprecipitation with an extracellular domain-specific antibody. Specific interactions found between these receptors were independent of ligand binding or an intact ATP-binding site. Truncated receptors that had sequences necessary for membrane localization, and that were capable of interacting with full-length receptor tyrosine kinase, also displayed constitutive kinase activity as well as the capacity to transphosphorylate kinase-negative receptors. Receptor co-immunoprecipitation occurred between constructs that comprise the intracellular domains of the epidermal growth factor and β-platelet-derived growth factor receptors, and HER-2. Subsequent deletion analysis has identified the major region of epidermal growth factor receptor intracellular interaction to be within the kinase domain.

    Footnotes

    • * Funding was provided by the Trustees Research Committee of Charing Cross Hospital and the Nuffield Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • 1 The abbreviations used are:

      EGF

      epidermal growth factor

      RTK

      receptor tyrosine kinase

      PDGF

      platelet-derived growth factor

      PDGF-R

      PDGF receptor

      DMEM

      Dulbecco's modified Eagle's medium

      PAGE

      polyacrylamide gel electrophoresis.

      • Received October 4, 1994.
      • Revision received December 2, 1994.
    « Previous | Next Article »Table of Contents
    • Advertisement
    • Advertisement
    Advertisement